NO924138L - Kinolinderivater, fremgangsmaate for deres fremstilling ogderes terapeutiske anvendelse - Google Patents

Kinolinderivater, fremgangsmaate for deres fremstilling ogderes terapeutiske anvendelse

Info

Publication number
NO924138L
NO924138L NO92924138A NO924138A NO924138L NO 924138 L NO924138 L NO 924138L NO 92924138 A NO92924138 A NO 92924138A NO 924138 A NO924138 A NO 924138A NO 924138 L NO924138 L NO 924138L
Authority
NO
Norway
Prior art keywords
group
alkoxy
procedure
preparation
aryl
Prior art date
Application number
NO92924138A
Other languages
English (en)
Norwegian (no)
Other versions
NO924138D0 (no
Inventor
Gerard Cremer
Pascale Goberville
Jean-Claude Muller
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9418349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO924138(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO924138D0 publication Critical patent/NO924138D0/no
Publication of NO924138L publication Critical patent/NO924138L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Communication Cables (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
NO92924138A 1991-10-28 1992-10-27 Kinolinderivater, fremgangsmaate for deres fremstilling ogderes terapeutiske anvendelse NO924138L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9113240A FR2683819B1 (fr) 1991-10-28 1991-10-28 Derives de quinoleine, leur procede de preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
NO924138D0 NO924138D0 (no) 1992-10-27
NO924138L true NO924138L (no) 1993-04-29

Family

ID=9418349

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924138A NO924138L (no) 1991-10-28 1992-10-27 Kinolinderivater, fremgangsmaate for deres fremstilling ogderes terapeutiske anvendelse

Country Status (18)

Country Link
EP (1) EP0540400B1 (zh)
JP (1) JPH05239053A (zh)
KR (1) KR930007935A (zh)
CN (1) CN1073171A (zh)
AT (1) ATE126798T1 (zh)
AU (1) AU651740B2 (zh)
CA (1) CA2081537A1 (zh)
CZ (1) CZ324292A3 (zh)
DE (1) DE69204252T2 (zh)
FI (1) FI924869A (zh)
FR (1) FR2683819B1 (zh)
HU (1) HUT62883A (zh)
IL (1) IL103568A0 (zh)
MX (1) MX9206169A (zh)
NO (1) NO924138L (zh)
NZ (1) NZ244892A (zh)
PL (1) PL296369A1 (zh)
ZA (1) ZA928297B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478832A (en) * 1992-05-08 1995-12-26 The Green Cross Corporation Quinoline compounds
IT1255461B (it) * 1992-07-28 1995-11-02 Luso Farmaco Inst Eteri di imidazoli ad attivita' a ii antagonista
FR2699174B1 (fr) * 1992-12-14 1995-01-20 Synthelabo Dérivés de 3-(quinoléin-6-yl-méthyl)-4H-imidazol-4-one, leur préparation et leur application en thérapeutique.
FR2710914B1 (fr) * 1993-10-04 1995-11-24 Synthelabo Dérivés de 2-[2-(tétrazol-5-yl)phényl]-1,2-dihydroquinoléine, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2716196B1 (fr) * 1994-02-16 1996-04-05 Synthelabo Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique.
JPH09202774A (ja) 1996-01-25 1997-08-05 Green Cross Corp:The ２−アリールキノリン類およびその製造方法
DE19706161A1 (de) * 1997-02-17 1998-08-20 Oswald Hartmut Prof Dr Med Verwendung von Cyaninen, Isocyaninen und Pseudoisocyaninen als Diuretika
KR100744826B1 (ko) * 2006-04-05 2007-08-01 한국화학연구원 이미다졸기가 치환된 퀴놀리논 유도체
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103804349A (zh) * 2012-11-01 2014-05-21 杨子娇 一类治疗青光眼的化合物及其用途
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
CN108558750B (zh) * 2018-07-11 2021-01-05 武汉工程大学 无溶剂法合成3-硝基喹啉衍生物的工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
DE4117750A1 (de) * 1991-05-30 1992-12-24 Bayer Ag Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DK0528762T3 (da) * 1991-08-15 1997-08-25 Ciba Geigy Ag N-acyl-N-heterocyclyl- eller naphthylalkyl-aminosyrer som angiotensin II antagonister

Also Published As

Publication number Publication date
FR2683819B1 (fr) 1994-02-11
EP0540400B1 (fr) 1995-08-23
AU651740B2 (en) 1994-07-28
IL103568A0 (en) 1993-03-15
CA2081537A1 (en) 1993-04-29
PL296369A1 (en) 1993-05-31
JPH05239053A (ja) 1993-09-17
MX9206169A (es) 1993-07-01
EP0540400A1 (fr) 1993-05-05
ATE126798T1 (de) 1995-09-15
CN1073171A (zh) 1993-06-16
HUT62883A (en) 1993-06-28
FI924869A0 (fi) 1992-10-27
FR2683819A1 (fr) 1993-05-21
KR930007935A (ko) 1993-05-20
AU2734892A (en) 1993-04-29
NZ244892A (en) 1994-06-27
ZA928297B (en) 1993-05-07
DE69204252D1 (de) 1995-09-28
HU9203374D0 (en) 1993-01-28
NO924138D0 (no) 1992-10-27
FI924869A (fi) 1993-04-29
DE69204252T2 (de) 1996-04-18
CZ324292A3 (en) 1993-09-15

Similar Documents

Publication Publication Date Title
NO924138L (no) Kinolinderivater, fremgangsmaate for deres fremstilling ogderes terapeutiske anvendelse
DK0500409T3 (da) Derivater af 4-pyrimidinoler, deres fremstilling og anvendelse i therapien
DE69116930D1 (de) Fluorierte Bis(hydroxymethyl)cyclobutylpurine und -pyrimidine
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
ES517042A0 (es) Procedimiento para la preparacion de una aroilimidazolidin-2-ona.
DK0508955T3 (da) Anvendelse af 2-iminothiazolidin-4-onderivater som nye lægemidler
DK599486A (da) 1,4-dihydropyridiner, deres fremstilling af anvendelse som laegemidler
ATE134607T1 (de) Tetrahydronaphtalenderivate, ihre herstellung und ihre therapeutische verwendung
DK0461012T3 (da) Derivater af ((1-arylpyrrolidin-2-yl)methyl)piperazin, fremstillingen heraf og deres terapeutiske anvendelse
DE69320542D1 (de) Pyrrolothienopyrazin-Verbindungen als 5HT3-Rezeptoren-Antagonisten